Cipla Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 85.00 Cr
as on 17-06-2024
- Paid Up Capital ₹ 72.00 Cr
as on 17-06-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 128.94%
(FY 2023)
- Profit -1.62%
(FY 2023)
- Ebitda -16.82%
(FY 2023)
- Net Worth 140.13%
(FY 2023)
- Total Assets 131.94%
(FY 2023)
About Cipla Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 85.00 Cr and a paid-up capital of Rs 72.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Cipla Pharmaceuticals Limited India are Anil Choudhary as CFO and Rahul Verma as Company Secretary. Rajendra Chopra, Geena Malhotra, Anisha Udeshi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239MH2019PLC333266
- Company No.
333266
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
19 Nov 2019
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Cipla Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Choudhary | CFO | 24-Aug-2023 | Current |
| Rahul Verma | Company Secretary | 09-May-2020 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Jain  | Director | 19-Nov-2019 | Current |
| Anisha Udeshi | Director | 01-Jul-2021 | Current |
| Rajendra Chopra | Director | 19-Nov-2019 | Current |
| Geena Malhotra | Director | 01-Jul-2021 | Current |
Financial Performance and Corporate Structure Insights of Cipla Pharmaceuticals.
Cipla Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 128.94% increase. The company also saw a slight decrease in profitability, with a 1.62% decrease in profit. The company's net worth Soared by an impressive increase of 140.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cipla Pharmaceuticals?
In 2023, Cipla Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medispray Laboratories Private LimitedActive 32 years 9 monthsAnisha Udeshi and Dinesh Jain are mutual person
Goldencross Pharma LimitedActive 24 years 11 monthsRajendra Chopra, Anisha Udeshi and 1 more are mutual person
- Cipla Digital Health LimitedActive 2 years 9 months
Rajendra Chopra, Anisha Udeshi and 1 more are mutual person
Cipla Pharma And Life Sciences LimitedActive 16 years 4 monthsRajendra Chopra and Anisha Udeshi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cipla Pharmaceuticals?
Cipla Pharmaceuticals has a workforce of 10 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cipla Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cipla Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
